Myeloma Center


February 8, 2021

Husband and Wife Unite in Battling Myeloma

Linda Haymes

“We have been well taken care of at UAMS,” said Jerilee Gott of Sherwood, Arkansas who is a myeloma survivor along with her husband Ken. “The staff has been outstanding, and we feel we are in very good hands. Our future is very encouraging with the treatment options available for those who go into remission.”

When Jerilee and Ken Gott moved to Arkansas from New Mexico in late 2017 to be closer to their two daughters and grandchildren, she knew she would need regular checkups at the UAMS Myeloma Center. She was diagnosed with multiple myeloma, a cancer of the plasma cells in the blood, in 2009. But Jerilee Gott,…


January 19, 2021

UAMS Myeloma Center Social Work Manager Appointed to National Board

Linda Haymes

Harold Dean, LCSW, OCW-C

LITTLE ROCK — The Board of Oncology Social Work Certification (BOSWC) recently chose Harold Dean, LCSW, OCW-C, clinical social work program manager for the Myeloma Center at the University of Arkansas for Medical Sciences (UAMS) to serve on its board. Dean will serve for three years. The BOSWC, established in 2003, promotes excellence in psychosocial…


December 9, 2020

Myeloma Survivor Grateful for Time with Grandchildren

Linda Haymes

“Growing old with my husband, watching my grandchildren grow up and spending time with my family and friends were some of the things I thought I might miss,” Linda Cancienne of Alabaster, Alabama, said, recalling being diagnosed with myeloma in 2001 when she was 59.

Linda Cancienne of Alabaster, Alabama, and her husband, Mike, recently celebrated their 55th wedding anniversary by gathering with family around a backyard fire pit, socially distancing and wearing masks. “We went to our daughter’s house and enjoyed being together and recalling good memories,” Cancienne said. “I sure do miss hugging, though.” There was a time…


December 7, 2020

UAMS Physician Establishes Second International Guidelines for Treating Castleman Disease

Linda Haymes

“Castleman disease is rare so people don’t know how to treat it and until recently there has not been any systematic approach to unicentric Castleman disease,” said Frits van Rhee M.D., Ph.D., an international expert on Castleman disease. “These guidelines are meant to give treating physicians a framework for the diagnosis and treatment of UCD.”

LITTLE ROCK — Frits van Rhee, M.D., Ph.D., a myeloma researcher and clinician at the University of Arkansas for Medical Sciences (UAMS), was lead author on a recently published paper that establishes consensus diagnosis and treatment guidelines for a form of Castleman disease, a rare disorder of the lymph nodes and related tissues. The recommendations…


October 12, 2020

Social Work Manager: Being Social and Safe During the Holidays

Linda Haymes

Harold Dean

“Wearing a mask is not a political statement,” said Harold Dean, LCSW, OSW-C, clinical social work program manager for the UAMS Myeloma Center. “Instead, it is a matter of public safety,” he told blood cancer patients during a recent virtual support group meeting. Dean is co-facilitator for the Leukemia and Lymphoma Society – Arkansas Division’s…


September 21, 2020

Retired UAMS HR Chief Shares Myeloma Journey through Blog

Linda Haymes

“The staff at the UAMS Myeloma Center has always made me feel like they are concerned about my well-being and that I get the best of medical and bedside care available,” said Hosea Long of Little Rock, former associate vice chancellor and chief human resources officer, and a 20-year survivor of myeloma.

Hosea Long of Little Rock recently turned 70, a milestone that for most may seem unremarkable. After all, it was not the former UAMS employee’s 100th, 90th or even his 80th birthday. But it was inspiring and incredible for him and his loved ones. Long explained why in a recent entry titled “Tomorrow starts a…


September 16, 2020

UAMS Researcher Delgado-Calle Awarded $1.7 Million to Study Bone Health in Myeloma Patients

Linda Haymes

Jesus Delgado-Calle, Ph.D., an assistant professor at the University of Arkansas for Medical Sciences, has been awarded a National Cancer Institute grant of more than $1.7 million to study bone health in myeloma patients and the effectiveness of bone therapies.

LITTLE ROCK —Jesus Delgado-Calle, Ph.D., an assistant professor at the University of Arkansas for Medical Sciences (UAMS), has been awarded a National Cancer Institute grant of more than $1.7 million to study ways bone therapy might repair damaged bone and prevent or delay relapse in myeloma patients. Multiple myeloma, a cancer of the plasma cells…


September 14, 2020

UAMS Partners Card Offers Shoppers and Diners 20% Discount at About 200 Locations

Susan Van Dusen

Partners Card logo

About 200 shops and restaurants in central and northwest Arkansas and Conway will offer discounts Oct. 30 – Nov. 8 with Partners Card, a fundraising project of the volunteer auxiliary of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS).


August 28, 2020

Frits van Rhee, M.D., Ph.D., Named Cancer Institute Auxiliary Distinguished Honoree

Susan Van Dusen

Dr. Frits van Rhee

From the safety and comfort of their homes, 46 guests gathered at their computers Aug. 21 to recognize one of the UAMS Winthrop P. Rockefeller Cancer Institute’s highly respected physicians: Frits van Rhee, M.D., Ph.D. At the virtual reception, van Rhee was presented with the Distinguished Honoree Award, a presentation made annually by the Cancer…


July 23, 2020

Fenghuang “Frank” Zhan, M.D., Ph.D., Awarded Nearly $3.14 Million to Further Myeloma Research

Linda Haymes

Fenghuang “Frank” Zhan, M.D., Ph.D., Myeloma Center research director at the University of Arkansas for Medical Sciences (UAMS), has received two grants totaling almost $3.14 million to study the molecular genetics and drug resistance of multiple myeloma, the second-most common blood-related cancer.

LITTLE ROCK — Fenghuang “Frank” Zhan, M.D., Ph.D., Myeloma Center research director at the University of Arkansas for Medical Sciences (UAMS), has received two grants totaling almost $3.14 million to study the molecular genetics and drug resistance of multiple myeloma, the second-most common blood-related cancer. One grant from the U.S. Department of Defense provides $1.4…



Previous page Next page